Arcturus Therapeutics Holdings Inc. (ARCT) Financial Statements (2024 and earlier)

Company Profile

Business Address 10628 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments391,883370,492462,89571,353
Cash and cash equivalents391,883370,492462,89571,353
Restricted cash and investments    
Receivables2,7643,3672,1252,179
Other undisclosed current assets8,6865,1022,769758
Total current assets:403,333378,961467,78974,290
Noncurrent Assets
Operating lease, right-of-use asset32,5455,6185,1825,134
Property, plant and equipment12,4155,6433,3782,349
Long-term investments and receivables  515 263
Long-term investments  515 263
Restricted cash and investments2,0942,077107107
Total noncurrent assets:47,05413,8538,6677,853
TOTAL ASSETS:450,387392,814476,45682,143
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities37,68133,58131,41312,927
Accounts payable7,44910,05810,7745,793
Accrued liabilities30,23223,52320,6397,134
Deferred revenue28,64843,48218,1088,397
Debt 60,65522,474  
Total current liabilities:126,98499,53749,52121,324
Noncurrent Liabilities
Long-term debt and lease obligation 45,13517,87019,845
Long-term debt, excluding current maturities 40,63313,84514,995
Liabilities, other than long-term debt53,09119,93112,51215,182
Deferred revenue20,07119,93112,51215,182
Other liabilities2,804   
Operating lease, liability30,2164,5024,0254,850
Total noncurrent liabilities:53,09165,06630,38235,027
Total liabilities:180,075164,60379,90356,351
Equity
Equity, attributable to parent270,312228,211396,55325,792
Common stock27262615
Additional paid in capital608,426575,675540,34397,445
Accumulated deficit(338,141)(347,490)(143,816)(71,668)
Total equity:270,312228,211396,55325,792
TOTAL LIABILITIES AND EQUITY:450,387392,814476,45682,143

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues205,99912,3599,53920,789
Gross profit:205,99912,3599,53920,789
Operating expenses(193,822)(215,211)(81,063)(46,302)
Operating income (loss):12,177(202,852)(71,524)(25,513)
Nonoperating income (expense)(1,018)(1,337)(361)(446)
Gain (loss), foreign currency transaction, before tax(598)584  
Other nonoperating income (expense)(420)(1,921)(361)(446)
Interest and debt expense(900)(2,700)(900)(900)
Income (loss) from continuing operations before equity method investments, income taxes:10,259(206,889)(72,785)(26,859)
Income (loss) from equity method investments (515)515(263)(32)
Other undisclosed income from continuing operations before income taxes900   
Income (loss) from continuing operations before income taxes:10,644(206,374)(73,048)(26,891)
Income tax expense(1,295)   
Other undisclosed loss from continuing operations    
Income (loss) from continuing operations:9,349(206,374)(73,048)(26,891)
Loss before gain (loss) on sale of properties:(206,374)(73,048)(26,891)
Net income (loss):9,349(206,374)(73,048)(26,891)
Other undisclosed net income (loss) attributable to parent 2,700900900
Net income (loss) available to common stockholders, diluted:9,349(203,674)(72,148)(25,991)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):9,349(206,374)(73,048)(26,891)
Comprehensive income (loss):9,349(206,374)(73,048)(26,891)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 2,700900900
Comprehensive income (loss), net of tax, attributable to parent:9,349(203,674)(72,148)(25,991)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: